Latest Content

VR technology captures not only visual fields but a full “stack” of pretest results.

Catch up on the top stories in optometry during the week of December 1-December 5.

Under the terms of the agreement, Iolyx Therapeutics has granted Théa exclusive worldwide development and commercialization rights, excluding Asia, to ILYX-002 for the treatment of ocular surface diseases.

HUC1-394 is a peptide-based eye drop for dry eyes being developed by the company.

LFVR Eyewear allows for patient customization of their frames in part of its private label eyewear services, according to founder Travis LeFevre.

Most active ingredients in presbyopia-correcting eye drops, including pilocarpine, aceclidine, and carbachol, are direct-acting cholinergic agonists that activate the iris sphincter muscle, causing pupil constriction.

The survey was conducted by OnePoll on October 2025 and included 1000 US patients with dry eye.

This is the first submission for approval under the exclusive license and commercialization agreement for South Korea that was signed between LENZ and Lotus.

Cyclosporine ophthalmic emulsion 0.05% is a topical immunomodulator to increase tear production in patients whose tear production is thought to be reduced due to ocular inflammation associated with dry eye syndrome.

This year's conference brought eye care professionals insights, tips, and pearls.

Sleep plays a pivotal role in maintaining ocular health.

Mark Graham of Your Brand Eyewear shares his company's success stories regarding creating private label eyewear for practices.

Researchers performed a secondary analysis of the DREAM study data.